Skip to main content
Top
Published in: Journal of NeuroVirology 5/2017

01-10-2017

Neurological involvement in patients with acute/recent HIV-1 infection. A case-control study

Authors: Juan Ambrosioni, Francisca Artigues, David Nicolás, Judit Peñafiel, Fernando Agüero, Christian Manzardo, María Mar Mosquera, Sonsoles Sánchez-Palomino, Elisa De Lazzari, María A. Marcos, Montserrat Plana, José M. Miró, Hospital Clinic PHI Investigators

Published in: Journal of NeuroVirology | Issue 5/2017

Login to get access

Abstract

Primary HIV-1 infection is a relevant period for its virological and epidemiological consequences. Most patients present a symptomatic disease that can be potentially serious, but neurological involvement during primary HIV-1 infection has been poorly studied. The aim of this study was to describe the characteristics and outcomes of primary HIV-1 infection patients presenting neurological symptoms and to compare them with primary HIV-1 infection patients without neurological involvement. Retrospective case-control study (1:3) comparing primary HIV-1 infection patients with and without neurological involvement enrolled in the Acute/Recent Hospital Clinic PHI Cohort between 1997 and 2016. Matching criteria included age (±10 years), gender, year of diagnosis (±4 years), and Fiebig stage. The conditional logit model was used for comparisons. Fourteen out of 463 patients (3.02%) enrolled in the Acute/Recent Hospital Clinic PHI Cohort between 1997 and 2016 presented neurological symptoms. 28.5% of cases presented as meningitis and 71.5% as meningoencephalitis. Cerebrospinal fluid showed non-specific findings, including pleocytosis with lymphocyte predominance and increased protein levels. All cases required hospitalisation, whereas only 19% of the controls did. No other pathogen was identified in any case, but five patients initiated empirically antimicrobial treatment for other aetiologies until diagnosis was confirmed. CD4/CD8 ratio was significantly lower (p = 0.039) and plasmatic viral load significantly higher in the case group, compared to controls (p = 0.028). Risk factors, HIV-1 tropism, subtype distribution, and prescribed ART regimens were comparable between cases and controls. After 6 months on ART, 92% of cases had undetectable viral load, similar to controls, and CD4/CD8 ratio became also comparable between groups. All cases recovered rapidly with ART and were discharged without sequels. Neurological involvement during primary HIV-1 infection is unusual but serious, always requiring hospitalisation. Diagnosis is difficult because of the wide range of symptoms and similarities with other viral aetiologies. Neurological manifestations during primary HIV-1 infection are associated with a lower CD4/CD8 ratio and with a higher viral load than controls. Immediate ART initiation and rapid viral load decrease are required, allowing complete clinical recovery.
Literature
go back to reference Ambrosioni J, Nicolas D, Sued O, Aguero F, Manzardo C, Miro JM (2014) Update on antiretroviral treatment during primary HIV infection. Expert Rev Anti-Infect Ther 12:793–807CrossRefPubMed Ambrosioni J, Nicolas D, Sued O, Aguero F, Manzardo C, Miro JM (2014) Update on antiretroviral treatment during primary HIV infection. Expert Rev Anti-Infect Ther 12:793–807CrossRefPubMed
go back to reference Ambrosioni J, Sued O, Nicolas D, Parera M, Lopez-Dieguez M, Romero A, Aguero F, Marcos MA, Manzardo C, Zamora L, Gomez-Carrillo M, Gatell JM, Pumarola T, Miro JM (2015) Trends in transmission of drug resistance and prevalence of non-B subtypes in patients with acute or recent HIV-1 infection in Barcelona in the last 16 years (1997–2012). PLoS One 10:e0125837CrossRefPubMedPubMedCentral Ambrosioni J, Sued O, Nicolas D, Parera M, Lopez-Dieguez M, Romero A, Aguero F, Marcos MA, Manzardo C, Zamora L, Gomez-Carrillo M, Gatell JM, Pumarola T, Miro JM (2015) Trends in transmission of drug resistance and prevalence of non-B subtypes in patients with acute or recent HIV-1 infection in Barcelona in the last 16 years (1997–2012). PLoS One 10:e0125837CrossRefPubMedPubMedCentral
go back to reference Ambrosioni J, Nicolas D, Manzardo C, Aguero F, Blanco JL, Mosquera MM, Penafiel J, Gatell JM, Marcos MA, Miro JM (2017) Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection. J. Antimicrob. Chemother 72:205–209 Ambrosioni J, Nicolas D, Manzardo C, Aguero F, Blanco JL, Mosquera MM, Penafiel J, Gatell JM, Marcos MA, Miro JM (2017) Integrase strand-transfer inhibitor polymorphic and accessory resistance substitutions in patients with acute/recent HIV infection. J. Antimicrob. Chemother 72:205–209
go back to reference Arentzen M, Jubt F, Evers S, Hesselmann V, Fiori W, Reichelt D, Oelker-Grueneberg U, Schwindt W, Dziewas R, Husstedt IW (2015) Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART. Int J Neurosci 125:601–611CrossRefPubMed Arentzen M, Jubt F, Evers S, Hesselmann V, Fiori W, Reichelt D, Oelker-Grueneberg U, Schwindt W, Dziewas R, Husstedt IW (2015) Cerebrovascular events in HIV-infected patients: an analysis of a cohort of 3203 HIV+ patients during the times of cART. Int J Neurosci 125:601–611CrossRefPubMed
go back to reference Churchill MJ, Cowley DJ, Wesselingh SL, Gorry PR, Gray LR (2015) HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research. J Neuro-Oncol 21:290–300 Churchill MJ, Cowley DJ, Wesselingh SL, Gorry PR, Gray LR (2015) HIV-1 transcriptional regulation in the central nervous system and implications for HIV cure research. J Neuro-Oncol 21:290–300
go back to reference del Saz SV, Sued O, Falco V, Aguero F, Crespo M, Pumarola T, Curran A, Gatell JM, Pahissa A, Miro JM, Ribera E (2008) Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up. J Neuro-Oncol 14:474–479 del Saz SV, Sued O, Falco V, Aguero F, Crespo M, Pumarola T, Curran A, Gatell JM, Pahissa A, Miro JM, Ribera E (2008) Acute meningoencephalitis due to human immunodeficiency virus type 1 infection in 13 patients: clinical description and follow-up. J Neuro-Oncol 14:474–479
go back to reference Douvoyiannis M, Litman N (2009) Acute encephalopathy and multi-organ involvement with rhabdomyolysis during primary HIV infection. Int J Infect Dis 13:e299–e304CrossRefPubMed Douvoyiannis M, Litman N (2009) Acute encephalopathy and multi-organ involvement with rhabdomyolysis during primary HIV infection. Int J Infect Dis 13:e299–e304CrossRefPubMed
go back to reference Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871–1879CrossRefPubMed Fiebig EW, Wright DJ, Rawal BD, Garrett PE, Schumacher RT, Peddada L, Heldebrant C, Smith R, Conrad A, Kleinman SH, Busch MP (2003) Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 17:1871–1879CrossRefPubMed
go back to reference Letendre SL, Ellis RJ, Ances BM, McCutchan JA (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18:45–55PubMedPubMedCentral Letendre SL, Ellis RJ, Ances BM, McCutchan JA (2010) Neurologic complications of HIV disease and their treatment. Top HIV Med 18:45–55PubMedPubMedCentral
go back to reference Letendre SL, Mills AM, Tashima KT, Thomas DA, Min SS, Chen S, Song IH, Piscitelli SC (2014) ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects. Clin Infect Dis 59:1032–1037CrossRefPubMedPubMedCentral Letendre SL, Mills AM, Tashima KT, Thomas DA, Min SS, Chen S, Song IH, Piscitelli SC (2014) ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects. Clin Infect Dis 59:1032–1037CrossRefPubMedPubMedCentral
go back to reference McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543–555CrossRefPubMed McArthur JC, Brew BJ, Nath A (2005) Neurological complications of HIV infection. Lancet Neurol 4:543–555CrossRefPubMed
go back to reference Spudich SS, Ances BM (2015) CROI 2015: neurologic complications of HIV infection. Top Antivir Med 23:47–55PubMed Spudich SS, Ances BM (2015) CROI 2015: neurologic complications of HIV infection. Top Antivir Med 23:47–55PubMed
go back to reference Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B, Di PM, Ciuffreda D, Saracco A, Lazzarin A (2000) Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 30:962–965CrossRefPubMed Tambussi G, Gori A, Capiluppi B, Balotta C, Papagno L, Morandini B, Di PM, Ciuffreda D, Saracco A, Lazzarin A (2000) Neurological symptoms during primary human immunodeficiency virus (HIV) infection correlate with high levels of HIV RNA in cerebrospinal fluid. Clin Infect Dis 30:962–965CrossRefPubMed
go back to reference Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W (2004) Movement disorders and AIDS: a review. Parkinsonism Relat Disord 10:323–334CrossRefPubMed Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W (2004) Movement disorders and AIDS: a review. Parkinsonism Relat Disord 10:323–334CrossRefPubMed
Metadata
Title
Neurological involvement in patients with acute/recent HIV-1 infection. A case-control study
Authors
Juan Ambrosioni
Francisca Artigues
David Nicolás
Judit Peñafiel
Fernando Agüero
Christian Manzardo
María Mar Mosquera
Sonsoles Sánchez-Palomino
Elisa De Lazzari
María A. Marcos
Montserrat Plana
José M. Miró
Hospital Clinic PHI Investigators
Publication date
01-10-2017
Publisher
Springer International Publishing
Published in
Journal of NeuroVirology / Issue 5/2017
Print ISSN: 1355-0284
Electronic ISSN: 1538-2443
DOI
https://doi.org/10.1007/s13365-017-0548-6

Other articles of this Issue 5/2017

Journal of NeuroVirology 5/2017 Go to the issue